Searched for
PIRAMAL LIFE SCIENCES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Piramal Finance among 5 stocks showing bullish RSI upswingOn April 22, five Nifty500 stocks that gained over 3% appeared in the RSI Trending Up scan. The signal occurs when RSI crosses above 50 fro...
- Piramal Life Sciences promoter sells 28% stakePiramal Life Sciences promoter entity PHL Holdings today sold over 28 per cent stake in the the company to another group firm for about Rs ...
- Now, Indian pharma companies like Jubilant Group, TCG Life Sciences and Piramal Life Sciences venture to share new drug R&D risksIndian firms need handholding, but there have been times when they were left on their own after being assigned a project.
- DBT, Piramal Life partnership gets extensionThe department of biotechnology and Piramal Life Sciences have started second phase of drug discovery partnership to find new drugs from 14...
- Piramal Health hits 52-wk low, Piramal Life zoomsShares of Piramal Healthcare fell over 12 percent to hit 52-week low as investors gave a thumbs down to its planned financial services fora...
- Piramal Healthcare to float Piramal Finance with capital base of Rs 1,000 crorePiramal Healthcare has also acquired 100% stake in Indiareit Fund Advisors for Rs 110 crore and Indiareit Investment Management, for Rs 115...
- Piramal Life Sciences Q4 net loss at Rs 40.97 crPiramal Life Sciences today said its net loss widened to Rs 40.97 crore in the fourth quarter ended March 31, 2011.
- Heard on the Street: DB Realty, Piramal Life SciencesThe shares of DB Realty have jumped nearly 40% in the last two sessions, after taking a major hit amid continuous negative news flow relati...
- Piramal Life Sciences Dec quarter net loss at Rs 25.68 croreThe company had a net loss of Rs 36.76 crore in the quarter ended December 31, 2009, Piramal Life Sciences said in a filing to the Bombay S...
- Piramal Life Sciences Q2 net loss at Rs 39.47 crPiramal Life Sciences on Saturday posted a net loss of Rs 39.47 crore for the quarter ended September 30, 2010.
- Buy Suven Life Sciences on decline as a 2-3 month move: Hemen KapadiaHemen Kapadia, CEO, chartpundit.com in a chat with ET Now gives his take on Piramal Life Sciences and Suven Life Sciences.
- Piramal might place part of its equity with MNC: Seshadri Bharathan, KSEMA Fincon LtdSeshadri Bharathan, MD & CEO, KSEMA Fincon Ltd, in a chat with ET Now talks about Piramal Life Science.
- Pick Piramal Life Sciences for a target of Rs 130-135Sandeep Wagle, Founder & MD, Aptart Technical Advisory Services shares his views on Piramal Life Sciences' stock with ET Now.
- Sell Bajaj Hindustan and park equity in Piramal LifeSciences: Sanjeev AgarwalBajaj Hindustan is a sell below 200 while Piramal LifeSciences is a defensive stock one can park equity in.
- Piramal Life Sciences mulls Rs 200 cr investment in R&DPiramal Life Sciences, R&D arm of Piramal Group, is investing Rs 200 crore in next two year's period for its ambitious programme to discove...
- Emkay puts buy on Piramal Life Science; target Rs 270Emkay Global Financial Services has initiated ‘buy’ on Piramal Life Sciences for a target price of Rs 270.
- Piramal Life Sciences trading at Rs 500Piramal Life Sciences, the demerged drug research company of Nicholas Piramal, listed at Rs 391 on the NSE on Thursday. At 10:39 am, the sh...
- Piramal Group to list R&D arm by June; mulls PE placementHealthcare and pharma company Piramal Group on Tuesday said it will list its spun-off research and development arm, Piramal Life Sciences, ...
Load More- Piramal Life Sciences promoter sells 28% stake
